The FDA was an important member of the U.S. team that negotiated the U.S.-Mexico-Canada Agreement (USMCA), which came into effect on July 1 of this year. From the FDA`s perspective, the agreement adapts regulatory standards to public administration practices, improves the quality of products available to U.S. consumers and a level playing field for U.S. companies. The agreed text of the agreement was signed by the heads of state and government of the three countries on November 30, 2018, as an incidental event at the 2018 G20 summit in Buenos Aires, Argentina.  The English, Spanish and French versions will also be binding and the agreement will take effect after ratification by the three states through the adoption of enabling laws.  In addition to its work with the WTO, the United States has concluded trade agreements with 20 countries that cover a number of issues, ranging from tariffs on goods and access to the agricultural market to intellectual property and the environment. For the FDA, the specific themes are chapters of agreements on regulatory issues such as SPS measures, OBTs and good regulatory practices – as well as sector chapters on cosmetics, medical devices and drugs, if any. The FDA helps develop negotiation proposals in the United States and the FDA is actively involved in trade negotiations with U.S.
trading partners. An April 2019 Analysis by the International Trade Commission on the likely effects of the USMCA estimated that the agreement would increase U.S. real GDP by 0.35 percent if the agreement were fully implemented (six years after ratification) and would increase total U.S. employment by 0.12% (176,000 jobs).   The analysis cited by another Congressional Research Service study showed that the agreement would not have a measurable effect on employment, wages or overall economic growth.  In the summer of 2019, Larry Kudlow, Trump`s chief economic adviser (the director of the National Economic Council at Trump White House), made unfounded statements about the likely economic impact of the agreement and overstated forecasts related to jobs and GDP growth.  As of March 1, 2019, many agricultural organizations were represented in the United States.